CSL Seqirus, a business of CSL (ASX: CSL), announced recent data showing that cell-based influenza vaccines offer greater protection in preventing test-confirmed influenza compared to standard ...

CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.

Even in death, cells leave a trace. Scientists have discovered a microscopic “Footprint of Death” that not only helps the ...

Viruses have no metabolism of their own and must therefore infect host cells in order to replicate. Contact between the virus and the cell surface is a crucial first step, which can also prevent ...

The influenza virus manipulates the body’s gene regulation system to accelerate its own spread, according to researchers at the University of Gothenburg. Their study also shows that an already ...

The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.

Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...

December 12, 2011 — Children with sickle cell anemia who receive the trivalent inactivated influenza vaccine are no more likely to be hospitalized for sickle cell crisis than children with sickle cell ...

Findings indicate H5N1 virus stability in raw-milk cheese for 120 days, emphasizing the need for revised safety measures in dairy products to protect health.